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Abstract
Background: Viruses bind to specific cellular receptors in order to infect their hosts. The specific receptors a virus uses 
are important factors in determining host range, cellular tropism, and pathogenesis. For adenovirus, the existing model 
of entry requires two receptor interactions. First, the viral fiber protein binds Coxsackie and Adenovirus Receptor (CAR), 
its primary cellular receptor, which docks the virus to the cell surface. Next, viral penton base engages cellular integrins, 
coreceptors thought to be required exclusively for internalization and not contributing to binding. However, a number 
of studies reporting data which conflicts with this simple model have been published. These observations have led us 
to question the proposed two-step model for adenovirus infection.
Results: In this study we report that cells which express little to no CAR can be efficiently transduced by adenovirus. 
Using competition experiments between whole virus and soluble viral fiber protein or integrin blocking peptides, we 
show virus binding is not dependent on fiber binding to cells but rather on penton base binding cellular integrins. 
Further, we find that binding to low CAR expressing cells is inhibited specifically by a blocking antibody to integrin 
αvβ5, demonstrating that in these cells integrin αvβ5 and not CAR is required for adenovirus attachment. The binding 
mediated by integrin αvβ5 is extremely high affinity, in the picomolar range.
Conclusions: Our data further challenges the model of adenovirus infection in which binding to primary receptor CAR 
is required in order for subsequent interactions between adenovirus and integrins to initiate viral entry. In low CAR 
cells, binding occurs through integrin αvβ5, a receptor previously thought to be used exclusively in internalization. We 
show for the first time that integrin αvβ5 can be used as an alternate binding receptor.
Background
Viruses bind to specific cellular receptors to infect their
hosts. The specific receptors a virus uses are important
factors in determining host range, cellular tropism, and
pathogenesis. HIV-1 is one of the best characterized
viruses in terms of viral entry. HIV-1 first binds to CD4,
its primary receptor [1,2]. Although CD4 binding was ini-
tially thought to be sufficient for infection, it was later
found that a second interaction between HIV and
chemokine co-receptors CCR5 or CXCR4, is also
required [3-5]. Binding to CD4 occurs first, triggering
conformational changes in the HIV protein gp120,
revealing the previously hidden binding site for its co-
receptors, which then trigger membrane fusion [6,7]. The
discovery of HIV's requirement for co-receptors in addi-
tion to CD4 represented a significant shift in our under-
standing of viral entry. The idea that a single virus bound
to a single entry receptor was replaced with the idea that
viral entry is the result of distinct sequential events
requiring multiple surface proteins.
In keeping with this multistep entry model, adenovi-
ruses have been proposed to use a primary receptor to
mediate binding and co-receptors to mediate internaliza-
tion [8]. Adenoviruses are non-enveloped double
stranded DNA viruses associated with respiratory dis-
ease, ocular disease, and gastroenteritis [9]. Adenoviruses
have three major capsid proteins: hexon, which forms the
bulk of the capsid and is present in 240 copies, penton
base, which is present in five copies at each of the twelve
vertices, and fiber, a homotrimeric protein that protrudes
from each vertice, extending outward from the penton
base. More than 50 human serotypes of adenovirus have
been identified to date [10,11]. The best studied of these
are the species C adenoviruses, including Adenovirus
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Serotype 2 (Ad2) and Adenovirus Serotype 5 (Ad5). The
primary receptor for species C adenoviruses is thought to
be Coxsackie and Adenovirus Receptor (CAR), which
binds to the globular knob domain of fiber [12]. This high
affinity interaction docks the virus to the cell, thus allow-
ing secondary interactions to occur. Following fiber bind-
ing to CAR, the penton base engages αvβ3 and αvβ5
integrins to initiate endocytosis and viral entry [8]. Aden-
oviruses bind to integrins via an RGD motif present in the
penton base. The penton base-integrin interaction is pro-
posed to be exclusively involved in virus internalization
and not to contribute to virus binding [8].
Several studies have reported alternate mechanisms for
adenovirus entry. Huang et al demonstrated that adenovi-
rus binds to hematopoietic cells via a penton base inter-
action with Integrin αMβ2, an integrin not expressed on
epithelial cells, but still requires αv integrins for virus
internalization [13]. Additionally, Ad5 has also been pro-
posed to use heparan sulphate glycosaminoglycans as
receptors [14,15] and to use lactoferrin as a bridge
between viral particles and the cell surface [16,17]. In
both of these systems, adenovirus fiber is the viral protein
required for binding. Further complication is observed in
vivo. Infection of liver cells, which has been well charac-
terized, is CAR-independent and instead depends on ade-
novirus hexon binding the blood coagulation factor F(X)
which leads to infection [18-24]. Additionally, in both
mice and non-human primates, adenoviruses with
m u t a n t  fi be r s  a b l a t ed  f o r  CAR  b i n d i n g  s h o w  a  s i m i la r
biodistribution compared to wild type viruses
[18,21,25,26]. Similarly, a lack of correlation between
CAR expression and adenovirus infection has been
observed in cell lines, though the mechanism by which
infection of cells with low CAR is achieved is undefined
[12,27,28].
We also observe a lack of correlation between CAR
expression and infection in cell lines. Indeed, we report
here that an Ad5 vector can efficiently transduce cancer
cells which express little to no CAR. Further, Ad5 binds to
these cells via integrin αvβ5, a surface protein previously
thought to be used exclusively for internalization and
thus classified as a secondary co-receptor. These observa-
tions lead us to further question the two-step model for
adenovirus infection, in which adenovirus must first bind
to CAR, the primary receptor, in order to bind to integ-
rins and trigger viral entry.
Results
Adenovirus infection is variable across a panel of cancer 
cell lines
Although alternate entry routes have been described, the
best characterized model of adenovirus entry requires
binding of adenovirus fiber to the cellular membrane pro-
tein CAR to initiate infection [12]. CAR is a cell adhesion
molecule and, like other cell adhesion molecules, is
down-regulated during cancer progression [29-34]. Sev-
eral reports have shown that the ability of adenoviruses to
infect different cancer cell lines is variable [31,33-36].
Therefore, we chose a panel of cancer cell lines, consist-
ing of human melanoma cells and human breast cancer
cells, to study the requirement for a CAR-mediated bind-
ing event in adenovirus infection. We first measured the
ability of Ad5 to infect this panel of cancer cell lines. Cells
were infected with a non-replicating virus deleted for
E1A that expresses GFP (Ad5-GFP) and GFP expression
was used as a measure of transduction. Cells were
infected at a multiplicity of infection (MOI) 25 because at
this MOI cells show a high level of transduction but the
system is not saturated (Additional File 1). Figure 1 shows
that at MOI 25, Ad5-GFP transduced these cells with a
wide range of efficiency. The percentage of cells positive
for GFP as well as the mean fluorescence intensity (MFI)
for each cell line is displayed in Table 1. SkMel2 cells were
most infectible with 97% of cells positive for GFP. MDA-
MB-435, MCF7, MDA-MB-231, and MDA-MB-453 cells
were infected at an intermediate level, ranging from 58-
79% of cells GFP-positive. On the lower end of the spec-
trum, Ad5-GFP infected only about 40% of both BT549
and WM278 cells. Finally, T47D cells show a very small
shift in fluorescence after infection, indicating these cells
are resistant to Ad5 infection.
Table 1: Quantification of Ad5 transduction and CAR 
expression across the panel of cell lines
Transduction CAR Expression
Cell Line % positive MFI % positive MFI
SkMel2 97.1 575 98.3 68.3
MDA-MB-231 69.3 438 93.5 31.2
BT549 35.5 86.2 42.2 12.6
MDA-MB-453 58.1 78.3 98.1 40
MDA-MB-435 79.2 657 0.5 3.9
MCF7 67 673 2.9 4.9
WM278 45.9 186 2.8 12.6
T47D 13.6 50.6 71.8 32.2
Quantification of data displayed in Figure 1 (Transduction) and 
Figure 2a (CAR expression). MFI is mean fluorescence intensity.Lyle and McCormick Virology Journal 2010, 7:148
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Figure 1 Ad5 transduction is variable across a panel of cancer cell lines. Cells were infected with Ad5-GFP at MOI (PFU/cell) 25 and incubated 
overnight. Infection was quantified immediately following the overnight incubation using flow cytometry analysis of cells infected with Ad5-GFP 
(black line) compared to an uninfected control (grey line) for each cell line. 10000 events were acquired and live cells were gated before assessing 
fluorescence. The percentage of cells positive for GFP is quantified as well as the mean fluorescence intensity (MFI) in Table 1. Data shown is repre-
sentative of at least two independent experiments.
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Surface CAR levels do not explain differences in Ad5 entry
CAR expression is a primary determinant for Ad5 entry.
To investigate whether the variability in transduction
could be explained by differences in CAR levels, we next
measured surface CAR expression using flow cytometry.
F i g u r e  2 a  s h o w s  t h a t  m o s t  o f  t h e  c e l l  l i n e s ,  i n c l u d i n g
SkMel2, MDA-MB-231, MDA-MB-453 and T47D cells,
express CAR on the majority of cells. Interestingly, T47D
cells, which are resistant to Ad5 infection, also express
CAR on the cell surface. In contrast, WM278, MDA-MB-
435, and MCF7 cells, all of which are infectible with Ad5-
GFP, express little to no CAR on the cell surface. Quanti-
fication of both the percentage of cells positive for CAR
e x p r e s s i o n  a s  w e l l  a s  t h e  M F I  i s  d i s p l a y e d  i n  T a b l e  1 .
These data suggests CAR binding is neither sufficient nor
necessary for Ad5 entry.
We next verified CAR expression by measuring mRNA
levels in two high CAR and two low CAR cell lines using
TaqMan analysis. Figure 2b shows that CAR mRNA levels
correlated with surface protein levels (Figure 2b). The
two cell lines (MDA-MB-435, and MCF7) which show lit-
tle to no surface CAR expression also had very little to, in
the case of MDA-MB-435 cells, no detectable CAR
mRNA expressed (Figure 2b).
Infection of CAR-negative cells is fiber-independent
Previous reports have indicated that the fiber-CAR inter-
a c t i o n  m e d i a t e s  b i n d i n g  o f  A d 5  t o  t h e  c e l l  s u r f a c e
[8,12,37]. Additionally, Ad5 fiber has been reported to
bind cells through heparin sulphate proteoglycans or
through a lactoferrin bridge [14-17]. Therefore, we next
examined whether Ad5 infection, although not depen-
dent on CAR, is still dependent on fiber, perhaps by bind-
ing to a different cellular receptor. To address this
question, we tested the dependence of infection in low
CAR cells on fiber. Cells were preincubated with soluble
fiber prior to adding Ad5-GFP to the cells and measuring
transduction, as determined by GFP expression. Trans-
duction of MDA-MB-231 and SkMel2 cells, both of
which express CAR (Figure 2), could be blocked in a
dose-dependent manner by preincubation with soluble
fiber (Figure 3). In contrast, transduction of low CAR
cells MCF7 and MDA-MB-435 was not blocked. Ad5
infection of MCF7 and MDA-MB-435 cells is therefore
not only CAR-independent but also fiber-independent.
Interestingly, at the highest concentration, preincubation
with fiber actually increases transduction in MCF7 cells.
Binding to CAR-negative cells is integrin-dependent
Our fiber blocking studies ruled out the possibility that
fiber binds an alternate receptor in CAR-negative cells. A
second well-characterized interaction between Ad5 and
the cell surface is the binding of the RGD (Arg-Gly-Asp)
domain in the penton base of adenovirus to integrin αvβ3
and integrin αvβ5 [8]. Integrins are heterodimeric cell
surface molecules that mediate cell-extracellular matrix
and cell-cell interactions and are therefore involved in a
number of cellular processes [38]. Additionally, several
viruses and bacteria have been reported to use integrins
to enter host cells [39-42]. Integrin-mediated processes
are often regulated by both ligand binding and integrin
clustering; therefore, many integrin ligands are multiva-
lent, able to bind multiple integrins simultaneously [43].
The crystal structure of the RGD domain of the adenovi-
rus penton base binding integrin αvβ5 has been resolved,
revealing that one penton base complex of the virus binds
approximately four integrin molecules [44]. Blocking
binding to integrin αvβ5, as well as αvβ3, prevents adeno-
virus from being internalized but does not impact bind-
ing of adenovirus to the cell surface [8]. Although these
studies predate the discovery of CAR, the cells used in
them expressed a fiber receptor, most likely CAR, as
infection of the cells could be blocked by soluble fiber [8].
Another study suggests integrin α3β1 can bind Ad5 to
cells, both in the presence and absence of CAR, although
the mechanism of this binding is unclear since it appar-
ently is not mediated by the RGD domain of Ad5 penton
base [45]. Additionally, Huang et al observed that in
hematopoietic cells lacking CAR, binding to the cell sur-
face is mediated by the leukocyte integrin αMβ2 [13].
Therefore, we sought to identify what role integrins play
in the infection of these low CAR cancer cells. To distin-
guish between two possibilities, binding and internaliza-
tion, we used an assay to directly measure binding. Cells
were plated in 96-well plates and incubated overnight at
37°C. Cells were chilled to 4°C, a temperature which
allows binding but does not permit internalization, and
then preincubated with increasing concentrations of an
integrin-blocking peptide, RGD, or a control peptide,
RGE. Ad5 was added to the cells at 4°C and incubated for
six hours. Cells were washed and fixed and virus bound
determined using an antibody directed against Ad5
capsid proteins. Figure 4a shows that in SkMel2 and
MDA-MB-231 cells, which express CAR, integrin block-
ing peptide RGD does not block Ad5 binding, consistent
with previous reports. However, in both MDA-MB-435
and MCF7 cells, which are low CAR, Ad5 binding to cells
is blocked by RGD, showing that binding in these cells is
integrin-dependent.
αvβ3, αvβ5, and the β1 subunithave been specifically
implicated in adenovirus infection [8,45-47]. Therefore,
we measured the levels of these integrins on the surface
of MDA-MB-435 and MCF7 cells, both of which lack
CAR expression, as well as SkMel2 and MDA-MB-231
cells, both of which express CAR. We found that MDA-
MB-435 and SkMel2 cells express all three integrins (Fig-
ure 4b). MCF7 and MDA-MB-231 cells only express αvβ5
and the β1 subunit (Figure 4b). The expression levels areLyle and McCormick Virology Journal 2010, 7:148
http://www.virologyj.com/content/7/1/148
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Figure 2 CAR expression levels. (A) Surface CAR levels were detected using flow cytometry. Cells were stained either with the monoclonal antibody 
RmcB which recognizes CAR (black line) or for control, only the secondary antibody, goat anti-mouse Alexa 488(grey line). The secondary only popu-
lation was set to approximately 1% positive and used as the negative population for each cell line. The percentage of cells which are positive for CAR 
as well as the MFI is quantified and displayed in Table 1. Data shown is representative of at least two independent experiments. (B) CAR mRNA levels 
were determined using quantitative real-time PCR. CAR mRNA levels are compared to the control gene GapDH and data is presented as a ratio of CAR: 
GapDH. Data is the average of at least two independent experiments and error bars represent standard deviation.
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quantified both by percentage of cells staining positive
and by MFI in Table 2.
Next, we investigated whether one of these integrins is
responsible for the binding of Ad5 to low CAR cells.
Again at 4°C to prevent virus internalization, cells were
preincubated with antibodies that block ligand binding to
integrins and then Ad5 was added to cells and the
amount of virus bound measured. Preincubation with
blocking antibodies to β1 or to αvβ3, in either MDA-MB-
435 or MCF7 cells, did not inhibit infection by very
much. However, blocking αvβ5 dramatically reduced Ad5
binding in both cell lines. In MDA-MB-435 cells, block-
ing αvβ5 reduced binding to only 5% of control and in
MCF7 cells, binding is reduced to 19% of control (Figure
4c). From this result, we conclude that binding of Ad5 to
low CAR cells occurs via the RGD domain of penton base
binding to integrin αvβ5.
Binding of Ad5 via integrin αvβ5 to CAR-negative cells is 
high affinity
To further characterize the interaction between Ad5 and
the surface of cells in which binding occurs via integrin
αvβ5, we measured the binding affinity of whole Ad5 and
the surface of MDA-MB-435 cells, which bind Ad5
through integrin αvβ5 (Figure 4c). Figure 5a shows bind-
ing to MDA-MB-435 cells is specific and saturable and
represents a typical binding isotherm. To determine the
dissociation constant (Kd), a measure of the strength of an
interaction, we fit the data to the Langmuir binding iso-
therm (Eqn 1) [48].
Here, Y is the fractional occupancy of the receptor and
[L] is the ligand concentration. We performed a non-lin-
ear least-squared analysis using MS Excel's Solver func-
tion to calculate the Kd. Figure 5b shows observed versus
calculated values of Y, demonstrating the observed values
fit this equation. We calculate a KD of 1.4 × 10-10 M.
Therefore, we conclude that Ad5 can bind to cells via
integrin αvβ5 and this interaction is high affinity, in the
picomolar range. Since previous studies have demon-
Y =
+
[]
([ ] )
L
kd L
(1)
Figure 3 Infection low CAR cells is fiber-independent. Cells were preincubated for 1 hr with increasing concentrations of soluble fiber followed by 
addition of Ad5-GFP and further incubation overnight. Flow cytometry was used to quantify fluorescence intensity. Data shown is the average of at 
least three independent experiments and error bars represent standard deviation. * indicates statistical significance, p ≤ 0.05.
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Figure 4 The role of integrins in infection of low CAR cells. (A) Cells were preincubated with media alone, increasing concentrations of synthetic 
peptide GRGDSP, or control peptide GRGESP for 1 hr followed by the addition of Ad5, all at 4°C for 6 hrs. Samples were then washed and fixed and 
virus bound was detected using an ELISA binding assay with an antibody to Ad5 as described in materials and methods. Data shown is the average 
of at least three independent experiments and error bars represent standard deviation. * indicates statistical significance, p ≤ 0.05. (B) Surface integrin 
levels were determined using flow cytometry. Cells were stained with LM609 (integrin αvβ3), P1F6 (integrin αvβ5), JB1A (integrin β1), or secondary 
only control, goat anti-mouse Alexa 488. The secondary only population was set to approximately 1% positive and used as the negative population 
for each cell line. The percentage of cells which are positive for each integrin as well as the MFI is quantified and displayed in Table 2. Data shown is 
representative of at least two independent experiments. (C) Cells were preincubated with media alone or the blocking antibodies LM609, P1F6, OR 
JB1A for 1 hr followed by the addition of Ad5, all at 4°C. Virus bound was determined as described in (A). Data shown is the average of at least three 
independent experiments and error bars represent standard deviation. * indicates statistical significance, p ≤ 0.05; ** indicates statistical significance, 
p ≤ 0.01.
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strated that one penton base can bind approximately 4
integrins, the multivalent nature of the penton base integ-
rin interaction likely contributes to the high affinity
observed [44].
Discussion
In this study we report that cells which do not express
CAR can be efficiently transduced by Ad5. Adenovirus
entry is not dependent on fiber binding to cells but
instead is blocked by an RGD peptide that interferes with
the RGD domain on the adenovirus penton base binding
cellular integrins. Further, we find that binding to low
CAR cells is inhibited specifically by a blocking antibody
to integrin αvβ5, demonstrating that integrin αvβ5 is
required for Ad5 attachment to these cells. The binding
mediated by integrin αvβ5 is extremely high affinity, in
the picomolar range. Our data further challenges the pre-
vailing model of adenovirus infection, in which binding to
a primary receptor, CAR, is required in order for subse-
quent interactions between adenovirus and integrins to
initiate viral entry.
Ad5 binding to low CAR cells is independent of fiber
and instead depends on an interaction with integrin αvβ5.
Therefore, Ad5 does not require an independent binding
receptor to dock it to the cell before it can interact with
internalization receptors. Other viruses are also reported
to use both primary binding and internalization recep-
tors. HIV-1 first binds to CD4 followed by binding to the
chemokine receptors CCR5 or CXCR4, which trigger
membrane fusion [49]. Binding to CD4 induces confor-
mational changes in the HIV protein gp120, revealing the
previously hidden binding site for its coreceptors [6].
Variants with mutations in gp120 allowing for direct
interaction with coreceptors have been isolated in vitro;
however, these variants are sensitive to neutralizing anti-
bodies and therefore selected against in vivo [50]. There-
fore, the role of CD4 binding in HIV-1 infection may be
particularly critical in evading the immune system of the
host.
Unlike HIV-1 binding to CD4, Ad5 binding to CAR
does not induce conformational changes in viral proteins,
thus facilitating subsequent entry steps [51]. Rather, CAR
is thought to facilitate a high affinity interaction to fiber,
thus docking the virus to the cell surface and allowing the
subsequent interaction between the penton base and
integrins to initiate internalization. Indeed, only the
extracellular domain of CAR is required for CAR-medi-
ated adenovirus entry [52]. However, previous studies
have observed CAR-independent infection and the work
in this paper demonstrates that Ad5 can bind directly to
integrin αvβ5, previously identified as an internalization
receptor [13,14,17,22,45]. Therefore, our results and the
results of others suggest this initial binding step is not
required for entry. Nevertheless, CAR binding is con-
served in a number of adenovirus serotypes and the fiber-
CAR interaction is one that is well characterized and is
itself of high affinity [10,53]. Therefore, CAR binding
clearly plays an important role in the adenovirus infection
cycle. One possibility is that, even when CAR is not
needed to enter cells, CAR functions as an exit receptor
[ 5 4 ] .  W a l t e r s  e t  a l  r e p o r t  t h a t  w h e n  A d 5  l y s e s  a  c e l l ,
excess fiber is released and through binding to CAR, dis-
rupts neighboring cell-cell junctions, allowing for release
of the virus back to the apical surface where it may con-
tinue infecting cells [54]. Additionally, recent work has
demonstrated that adenovirus binding to CAR may
induce downstream signaling events that increase integ-
rin activation, thus promoting infection[55]. Therefore,
binding to CAR may facilitate entry in ways beyond sim-
ply docking the virus to the cell surface. Indeed, at least
two serotypes of adenovirus, Ad9 and Ad37, have fibers
which bind CAR but do not use CAR as an attachment
receptor, supporting the idea that CAR binding is impor-
tant for steps other than attachment [10,56]. Further, it is
Table 2: Quantification of Integrins expression across panel of cell lines
αVβ3 expression αVβ5 expression β1 expression
Cell Line % positive MFI % positive MFI % positive MFI
SkMel2 79.5 28 69.9 26.6 99 52.8
MDA-MB-231 6.06 177 74.8 94.2 92.2 120
MDA-MB-435 6.28 107 94.8 110 99.4 68.3
M C F 7 4 . 5 3 2 . 27 5 . 94 8 . 48 4 . 36 3 . 9
Quantification of data displayed in Figure 4b. MFI is mean fluorescence intensity.Lyle and McCormick Virology Journal 2010, 7:148
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likely advantageous to the virus to be able to use multiple
entry routes, enabled by its ability to engage multiple dif-
ferent receptors.
Both HIV, as evidenced by CD4-independent variants
isolated in vitro, and Ad5, as evidenced by our results and
the results of others can infect cells without binding to
their so-called primary receptors. Binding to these recep-
tors, instead of being strictly required for infection, may
contribute to other necessary parts of the virus infection
cycle, such as evading the host immune system or facili-
tating virus escape. Many other viruses with less charac-
terized receptors seem to also use multiple receptors,
some classified as binding receptors [57]. For example,
rotaviruses are thought to first bind to a sialic acid (SA)-
containing molecule, which anchors the virus to the cell,
and then bind to coreceptors to initiate viral entry [57].
Mutant variants of rotaviruses that are SA-independent
and interact directly with coreceptors have been isolated
in vitro, suggesting that similarly to HIV and Ad5, bind-
ing to the primary receptor is not strictly required for
Figure 5 Ad5 binding to cells via integrin αvβ5 is high affinity. (A) Cells were incubated with various concentrations of Ad5 at 4°C for sufficient 
time for virus bound to reach equilibrium. Virus bound was measured as described in Figure 4. Y is the fractional occupancy, which is a ratio of virus 
bound to maximum virus bound. Data shown is the average of at least three independent experiments and error bars represent standard deviation. 
(B) Observed data (diamonds) was fit to calculated values (line) using the Langmuir Binding Isotherm (Eqn 1). Kd was determined by Microsoft Excel's 
Solver function using non-linear regression analysis to solve Eqn 1. A Kd of 1.4 × 10-10 M was calculated from the observed values.Lyle and McCormick Virology Journal 2010, 7:148
http://www.virologyj.com/content/7/1/148
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infection [58,59]. Therefore, the interaction between
rotaviruses and SA-containing molecules may facilitate
an as yet unidentified aspect of rotavirus infection. As
more functional roles of virus receptors in infection are
elucidated, the use of binding receptors in other aspects
of the viral life cycle may emerge as a general principle of
viral pathogenesis.
In addition to being used as a model system for viral
entry, much effort has been put into developing adenovi-
ruses, especially species C adenoviruses including Ad5, as
vectors for gene therapy. In fact, adenoviral vectors have
been used in more than one quarter of gene therapy trials
worldwide [60]. Cancer is one of the most common tar-
gets of adenovirus-mediated gene therapy. As mentioned
previously, CAR expression is often lost as cancers prog-
ress and this loss has been viewed as a major hurdle to
using adenovirus-based therapies in cancer [31,33-36].
However, integrin αvβ5 has been reported to be overex-
pressed in cancers [61,62]. Therefore, our conclusion that
Ad5 can use integrin αvβ5 to bind to and infect cells lack-
ing CAR suggests that cancer cells having lost CAR
expression may still be good targets for adenovirus-based
therapies. Recent work has shown that erythrocytes
sequester adenovirus by binding CAR, thus limiting sys-
temic infection; therefore, using CAR-ablated vectors, a
strategy many groups are attempting, may improve deliv-
ery for gene therapy for reasons beyond changing recep-
tor interactions [63,64]. We also observed what may be an
as yet unidentified obstacle to these therapies, however.
T47D cells, which express CAR (Figure 2a) and integrin
αvβ5 (data not shown) are still resistant to Ad5 infection
(Figure 1). Wang et al showed the cellular protein
CEACAM6 blocks adenovirus trafficking to the nucleus
in human pancreatic cancer cell lines[65]. Future studies
to determine if this protein blocks infection in T47D
cells, or if resistance is due to a novel mechanism are
needed.
Conclusions
In conclusion, we have found that cells which express lit-
tle to no CAR can still be efficiently transduced by Ad5.
In these cells, CAR is not required: Binding occurs
through integrin αvβ5. We show for the first time that
integrin αvβ5, previously described as an internalization
receptor, can also be used as an alternate binding recep-
tor for Ad5.
Methods
Cell Lines and Viruses
SkMel2 and WM278 cells are human melanoma cell lines.
MCF7, MDA-MB-453, BT549, T47D, MDA-MB-435, and
MDA-MB-231 are human breast cancer cell lines. All
cells were obtained from the ATCC. SkMel2 cells were
cultured in MEM supplemented with sodium pyruvate,
non-essential amino acids, and 10% FBS. WM278 were
cultured in DME-H16 and supplemented with 10% FBS.
All other cancer cell lines were cultured in DMEM sup-
plemented with 10% FBS. Virus used was replication
incompetent E1A deleted and expressed GFP (Ad5-GFP).
Virus was propagated in HEK293/E4/pIX cells and har-
vested by CsCl gradient ultracentrifugation as previously
described [66,67]. Virus titers were determined as previ-
ously described [68].
Antibodies and Peptides
The MAb RmcB was used to detect CAR expression [12].
The MAbs LM609, P1F6, and JB1A directed against inte-
grins αvβ3, αvβ5, and the β1 subunit respectively were
purchased from Chemicon. The secondary antibody
Alexa 488 was purchased from Molecular Probes. The
synthetic peptides GRGDSP and GRGESP were pur-
chased from Sigma. All antibodies were IgG.
Recombinant Fiber
Full length Ad5 fiber was cloned from a Gateway entry
vector into a his-tagged destination vector using the
Gateway system per manufacturer's instructions (Invitro-
gen). Fiber was transformed into and grown up in BL21
Star (DE3) E.coli (Invitrogen). Overnight starter culture
was diluted 1:100 in LB/amp and grown until bacteria
reached log phase. 50 uM IPTG was added and bacteria
were grown at room temperature overnight. Pellets were
disrupted using Bugbuster (Novagen) per manufacturer's
instructions. Fiber was purified via its his-tag by incuba-
tion with Probond resin (Invitrogen), several washes with
20 mM Imidizole, and elution using Poly-Prep Chroma-
tography Columns (BioRad) with 0.2 M Imidizole. Puri-
fied recombinant fiber was then dialyzed into PBS for use
in experiments. Approximately 1 mg/L of purified fiber
was obtained.
Cell Infection Assay
8 × 105 cells were plated in 6-well plates and incubated
overnight at 37°C. Cells were infected with Ad5-GFP at
MOI 25 in DMEM with 2% FBS. After overnight incuba-
tion at 37°C, cells were trypsinized, washed with PBS, and
GFP expression quantitated using flow cytometry. The
BD FACSCalibur Flow Cytometer is the instrument used,
10,000 events were acquired for each experiment, gating
for live cells, and FlowJo software was used to generate
histograms and analyze data. For fiber blocking experi-
ment, prior to addition of Ad5-GFP, different quantities
of soluble fiber (1 ug/mL, 5 ug/mL, or 25 ug/mL) were
added to cells, incubated at room temperature for 1 hr.
Then Ad5-GFP was added to cells at MOI 25 and cells
were incubated overnight at 37°C before flow cytometry
analysis.Lyle and McCormick Virology Journal 2010, 7:148
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Surface expression levels
Cells were trypsinized, washed with PBS, and 1 × 106 cells
were incubated with primary antibody for 30 minutes on
ice. Cells were washed, incubated with secondary for 30
minutes on ice, and analyzed by flow cytometry. The BD
FACSCalibur Flow Cytometer is the instrument used,
10,000 events were acquired for each experiment, gating
for live cells, and FlowJo software was used to generate
histograms and analyze data. Dilutions were as follows:
RmcB (1-50), LM609 (1-100), P1F6 (1-100), JB1A (1-100),
Alexa 488 (1-100). Secondary antibody (Alexa 488) alone
was used as a control for each cell line.
Statistics
Microsoft Excel was used to do a 2 tailed, type 3 T Test to
determine statistical significance.
Quantitative PCR
Total RNA was isolated from cells using RNeasy Mini Kit
(Qiagen). PCR was performed by the Genome Analysis
Core Facility, Helen Diller Family Comprehensive Cancer
Center, University of California, San Francisco. PCR was
conducted in triplicate with 20 uL reaction volumes of 1×
TaqMan buffer (1× Applied Biosystems PCR buffer, 20%
glycerol, 2.5% gelatin, 60 nM Rox as a passive reference),
5.5 mM MgCl2, 0.5 mM each primer, 0.2 uM each deoxy-
nucleotide triphosphate (dNTP), 200 nM probe, and
0.025 unit/uL AmpliTaq Gold (Applied Biosystems) with
5 ng cDNA. A large master mix of the above-mentioned
components (minus the primers, probe, and cDNA) was
made for each experiment and aliquoted into individual
tubes, one for each cDNA sample. cDNA was then added
to the aliquoted master mix. The master mix with cDNA
was aliquoted into a 384-well plate. The primers and
probes were mixed together and added to the master mix
and cDNA in the 384-well plate. PCR was conducted on
the ABI 7900HT (Applied Biosystems) using the follow-
ing cycle parameters: 1 cycle of 95° for 10 minutes and 40
cycles of 95° for 15 seconds, 60° for 1 minute. Analysis
was carried out using the SDS software (version 2.3) sup-
plied with the ABI 7900HT to determine the Ct values of
each reaction. Ct values were determined for three test
and three reference reactions in each sample, averaged,
and subtracted to obtain the ΔCt [ΔCt = Ct (test locus) –
Ct (control locus)]. PCR efficiencies were measured for
all custom assays and were greater than or equal to 90%.
Therefore, relative fold difference was calculated for each
primer/probe combination as 2-ΔCt × 100. PCR primer
and TaqMan probe sequences were synthesized by Inte-
grated DNA T echnologies (Coralville, IA) [or purchased
from Applied Biosystems]. The sequences were as follows
Human CAR
Amplicon:
GGCGCTCCTGCTGTGCTTCGTGCTCCTGTGCG
GAGTAGTGGATTTCGCCAGAAGTTTGAGTATCAC
TACTCCTGAAGAGATGATTGAAAAAGCCAAAG
Forward: GGCGCTCCTGCTGTGC
Reverse: CTTTGGCTTTTTCAATCATCTCTTC
Probe: TGCGGAGTAGTGGATTTCGCCAGAAG
Human GapDH:
Amplicon: ATTCCACCCATGGCAAATTCCATG
GCACCGTCAAGGCTGAGAACGGGAAGCTTGTCA
TCAATGGAAATCCCA
Forward: ATTCCACCCATGGCAAATTC
Reverse: TGGGATTTCCATTGATGACAAG
Probe: ATGGCACCGTCAAGGCTGAGAACG
Ad5 Binding Assay
Cells were plated in 96-well SigmaScreen poly-D-lysine
coated plates (Sigma) and incubated overnight at 37°C.
For peptide and antibody blocking experiments, cells
were prechilled at 4°C for 30 minutes followed by addi-
tion of either peptide at indicated concentration or anti-
body (500 ug/mL) for 1 hr. Ad5-GFP (0.04 ug/uL, protein
concentration determined by Bradford assay) diluted in
DMEM with 50% FBS was added to cells and incubated
for 6 hrs at 4°C. Cells were washed several times and fixed
with ice cold solution of 95% EtOH/5% Acetic Acid. Cells
were washed 1× TBST (0.05M Tris, 0.15 M NaCl, 0.5%
Tween-20, pH 7.5) and incubated in Superblock (Pierce)
for 1 hr at RT. Cells were washed 2× Superblock followed
by incubation with a non-related control IgG antibody to
block any non-specific interactions for 30 min, RT. Cells
were washed 1× TBST and incubated with polyclonal
rabbit anti-Ad5 antibody (Access Biomedical) for 30 min,
RT, followed by washing 4xTBST. Cells were next incu-
bated with Goat-anti-Rabbit-AP (Pierce) for 30 min, RT,
followed by washing 4xTBST. Signal was then amplified
and detected using an Elisa Amplification System per
manufacturer's instructions (Invitrogen). For determin-
ing KD of Ad5 binding to cells, the above protocol was
used except cells were incubated with Ad5 at varying
concentrations for 18 hrs at 4°C prior to fixing
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